scispace - formally typeset
N

Nicolás Olea

Researcher at University of Granada

Publications -  223
Citations -  18615

Nicolás Olea is an academic researcher from University of Granada. The author has contributed to research in topics: Population & Adipose tissue. The author has an hindex of 60, co-authored 207 publications receiving 16658 citations. Previous affiliations of Nicolás Olea include Carlos III Health Institute & Tufts University.

Papers
More filters
Journal ArticleDOI

Organochlorine pesticides in umbilical cord blood serum of women from Southern Spain and adherence to the Mediterranean diet

TL;DR: Investigation of the presence of nine OC residues in the umbilical cord blood of newborns in Southern Spain and the relationship of this exposure with maternal and pregnancy variables, including maternal adherence to the Mediterranean Diet, found no significant association between MD adherence and the presence in serum.
Journal ArticleDOI

Organochlorine pesticide exposure in children living in southern Spain.

TL;DR: Investigation of the presence of 16 OC pesticide residues in 52 fat samples collected from boys with a mean age of 7yr (0-15yr) living in Southern Spain found no statistically significant association was found between p,p'-DDE or SigmaDDTs and the birth year, birth weight, gestational age, infant feeding history or the age, weight, height or Quetelet Index at the time of sampling.
Journal ArticleDOI

Concentrations of bisphenol A and parabens in socks for infants and young children in Spain and their hormone-like activities

TL;DR: BPA appears to contribute to the hormone-like activity observed in sock extracts, and dermal exposure doses to BPA and parabens was higher from socks for children aged 36-48 months than from socks marketed for infants and children.
Journal ArticleDOI

Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

TL;DR: Results indicate that the euthyroid state partially reduces hyperthyroidism-associated osteopenia, with a bone mass recovery period during the 6-9 early months of effective treatment, characterized by raised bone formation markers and reduced bone resorption markers.
Journal ArticleDOI

Human exposure to endocrine-disrupting chemicals: assessing the total estrogenic xenobiotic burden

TL;DR: The work of this group is reported on developing a methodology to assess the total estrogenic burden, defined as the estrogenic activity in a bioassay of human samples from which ovarian estrogens have been previously eliminated.